| 1 |
Use of antibacterial fixed-dose combinations in the private sector in eight Latin American Countries between 1999 and 2009 |
|
|
| Veronika J. Wirtz,Peter G. M. Mol,Jonneke Verdijk,Robert H. Vander Stichele,Katja Taxis |
|
| Tropical Medicine & International Health. 2013; 18(4): 416 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 2 |
Sensitive LC-ESI/MS/MS assay for the quantification and pharmacokinetic study of roxithromycin in human serum |
|
|
| Yu Xu,Na Li,Yanan Luo,Junjie Sun,Bo Jiang,Qingxiang Guo |
|
| Journal of Analytical Chemistry. 2013; 68(8): 743 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 3 |
What does the growing prominence of Asia mean for pharmaceutical safety management? |
|
|
| Stewart Geary |
|
| Future Medicinal Chemistry. 2010; 2(10): 1503 |
|
| [HTML Full text] [Google Scholar] [DOI] |
|
| 4 |
Comparison of analgesic effects of nimesulide, paracetamol, and their combination in animal models |
|
|
| Ahmed, M., Upadhyaya, P., Seth, V. |
|
| Indian Journal of Pharmacology. 2010; 42(6): 354-357 |
|
| [Pubmed] [Google Scholar] |
|
| 5 |
What does the growing prominence of Asia mean for pharmaceutical safety management? |
|
|
| Geary, S. |
|
| Future Medicinal Chemistry. 2010; 2(10): 1503-1506 |
|
| [Pubmed] [Google Scholar] |
|
| 6 |
Prevalence of fixed dose drug combinations in nepal: A preliminary study |
|
|
| Poudel, A., Subish, P., Mishra, P., Mohamed Izham, M.I., Jayasekera, J. |
|
| Journal of Clinical and Diagnostic Research. 2010; 4(2): 2246-2252 |
|
| [Pubmed] [Google Scholar] |
|
| 7 |
Regulatory status of banned drugs in India |
|
|
| Shaji, J., Lodha, S. |
|
| Indian Journal of Pharmaceutical Education and Research. 2010; 44(1): 86-94 |
|
| [Pubmed] [Google Scholar] |
|
| 8 |
Irrational fixed dose combinations in Nepal: Need for intervention |
|
|
| Poudel, A., Palaian, S., Shankar, P.R., Jayasekera, J., Izham, M.I.M. |
|
| Kathmandu University Medical Journal. 2008; 6(23): 399-405 |
|
| [Pubmed] [Google Scholar] |
|
| 9 |
Fixed dose drug combinations (FDCs): Rational or irrational: A view point |
|
|
| Gautam, C.S., Saha, L. |
|
| British Journal of Clinical Pharmacology. 2008; 65(5): 795-796 |
|
| [Pubmed] [Google Scholar] |
|
| 10 |
Is the combination of enalapril and losartan irrational? |
|
|
| Parmar, D., Jadav, S. |
|
| Indian Journal of Pharmacology. 2008; 40(2): 91 |
|
| [Pubmed] [Google Scholar] |
|
| 11 |
Simultaneous determination and pharmacokinetic study of roxithromycin and ambroxol hydrochloride in human plasma by LC-MS/MS |
|
|
| Hang, T.-j., Zhang, M., Song, M., Shen, J.-p., Zhang, Y.-d. |
|
| Clinica Chimica Acta. 2007; 382((1-2)): 20-24 |
|
| [Pubmed] [Google Scholar] |
|
| 12 |
Simultaneous determination and pharmacokinetic study of roxithromycin and ambroxol hydrochloride in human plasma by LC-MS/MS |
|
|
| Tai-jun Hang,Meng Zhang,Min Song,Jian-ping Shen,Yin-di Zhang |
|
| Clinica Chimica Acta. 2007; 382(1-2): 20 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
| 13 |
Combined treatment with angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARB): æBeating a dead horseæ or meaningful mechanism-guided therapy? |
|
|
| Petroianu, G.A. |
|
| Indian Journal of Pharmacology. 2006; 38(5): 372-373 |
|
| [Pubmed] [Google Scholar] |
|
